Abbott Laboratories
ABT · Healthcare · · USDFahodi Score BUY Long-term (Investment)
70
/ 100
Technical
100
Trend & RS
71
Momentum
71
Fundamental
83
Macro
24
Liquidity
63
| Component | Score | Weight |
|---|---|---|
| Technical | 100.0 | 10% |
| Trend & RS | 71.0 | 10% |
| Momentum | 71.4 | 5% |
| Fundamental | 83.3 | 40% |
| Macro | 23.8 | 15% |
| Liquidity | 62.6 | 20% |
Trade Setup
| Entry | 110.61 |
| Stop Loss | 104.23 (5.8%) |
| Target 1 (1:1) | 117.00 (+5.8%) |
| Target 2 (2:1) | 123.38 (+11.5%) |
| ATR(14) | 3.19 (2.9%) |
| Risk per Share | 6.38 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 39.6 | -0.42 | |
| Momentum | 71.4 | +0.85 | |
| Quality | 35.0 | -0.60 | |
| Composite | 48.7 | ||
Quality Scores
Piotroski F-Score
6
/9 —
Average
✓
✓
✗
✗
✓
✗
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
5.62
—
Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe
Valuation vs Peers Overvalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 42.4 | 22.0 | +93% above |
| P/B Ratio | 3.9 | 4.0 | Inline |
| Dividend Yield | 2.2% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a premium to sector peers — verify growth justifies premium.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
55.70
vs
Market Price
113.60
Upside
-51.0%
| Margin of Safety | -103.9% |
| Stage 1 PV (5yr FCF) | 21,573,314,055 |
| Terminal Value PV | 74,896,837,044 |
| Total Enterprise Value | 96,470,151,099 |
Assumptions
| Base FCF | 3,713,282,793 |
| Growth Rate (5yr) | 14.5% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
45.8%
Full Kelly
22.9%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 70/100. Estimated win rate 61%, avg win 9.2%, avg loss 3.6%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
4
Bullish Signals
0
Bearish Signals
60.32
RSI(14)
2.5817
MACD
Relative Strength (RS) NEUTRAL
52
/ 99
RS Rating
O'Neil filter: <80
| RS vs SPY | → FLAT (+7.4% vs SPY 3M) |
| RS vs Sector | UNDERPERFORMING (Healthcare) |
| RS New High | Near 3-month high 2d since high |
| Sector Outperformance | -8.5% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
NEUTRAL:
In line with the market — no strong outperformance or underperformance.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 60.32 | NEUTRAL |
| Macd | 2.5817 | BULLISH |
| Ma Cross | 103.61 / 100.35 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.0x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 132.03 |
| Bollinger Upper | 113.85 |
| SMA(200) | 100.35 |
| SMA(50) | 103.61 |
| SMA(20) | 105.45 |
| Current Price | 113.60 |
| Bollinger Lower | 97.05 |
| 52-Week Low | 81.97 |
| ATR(14) | 3.19 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
ACCUMULATION E
Confidence
50%
Acc: 1.0 |
Dist: 1.0 |
Markup: 0.0 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-11-02 | Normal | 0.95x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.79x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.37x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.11x | Normal bar — no special VSA pattern |
| 2026-11-06 | Normal | 0.0x | Normal bar — no special VSA pattern |
Ichimoku Cloud BULLISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 109.31 | Above Kijun |
| Kijun-sen (26) | 105.77 | Base line |
| Senkou A | 107.54 | Leading span A |
| Senkou B | 105.77 | Leading span B |
| Cloud | 105.77 – 107.54 | Bullish (Green) |
| Price vs Cloud | 110.61 | Above Cloud |
| Chikou Span | 96.90 | Bullish |
| Alignment Score | 4/4 | BULLISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BULLISH FADING
BB: 97.05 – 113.85 | KC: 100.52 – 110.38
Divergences (last 60 bars)
No significant divergences detected in the last 60 bars.
Anchored VWAP
VWAP: 97.34
Anchor: 2026-05-11 (52w Low)
ABOVE AVWAP
+13.6%
Heikin-Ashi Trend
WEAKLY BEARISH
Full data via /api/advanced/ABT
Valuation
| Metric | Value |
|---|---|
| Market Cap | 196.75B |
| P/E (TTM) | 42.39 |
| Forward P/E | N/A |
| P/B | 3.86 |
| EPS | 2.68 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 14.5% |
| Profit Margin | 9.7% |
| ROE | 9.1% |
| Debt/Equity | 60.90 |
| Current Ratio | 1.46 |
| Dividend Yield | 2.2% |
| Payout Ratio | N/A |
| Beta | 0.54 |
Trading Data
113.60
Open
113.60
Day High
113.60
Day Low
10.26M
Volume (1.2x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)